Ledyard National Bank Has $211,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ledyard National Bank reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 404 shares of the medical equipment provider’s stock after selling 31 shares during the quarter. Ledyard National Bank’s holdings in Intuitive Surgical were worth $211,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of ISRG. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical in the third quarter worth about $38,000. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other news, insider Jamie Samath sold 269 shares of the company’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,940 shares of company stock valued at $3,333,485. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $582.98 on Friday. The business’s 50-day simple moving average is $554.03 and its 200-day simple moving average is $513.12. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a market capitalization of $207.65 billion, a PE ratio of 90.95, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.